Advertisement
News
Subscribe to MDT Magazine News

The Brain Stimulation Headset from Valkee Makes Light Work of Jet Lag, Job Stress and Winter Blues

June 1, 2011 12:34 am | by RealWire | Comments

The Brain Stimulation Headset, Valkee (http://www.valkee.com), substitutes the mood-elevating effects of the sun, by channelling safe bright light directly to photosensitive regions of the brain through the ear canal. Valkee has been proven to increase energy, and can act as a...

TOPICS:

Cigna names Nicoletti chief financial officer

May 31, 2011 3:45 pm | by The Associated Press | Comments

Health insurer Cigna Corp. announced Tuesday that Ralph Nicoletti has been named executive vice president and chief financial officer, starting June 20.Nicoletti succeeds Thomas McCarthy, the acting chief financial officer since September, who will become vice president of finance. Nicoletti...

P & G Welcomes New Members to U.S. Sustainability Expert Advisory Panel

May 31, 2011 12:35 pm | by Bio-Medicine.Org | Comments

CINCINNATI, May 31, 2011 /- The Procter & Gamble Company (NYSE: PG ) today announced that three new members have joined its U.S. Sustainability Expert Advisory Panel (SEAP). The new members are: Caroline Hermans, Ph.D. – Commitments Senior Manager, Clinton Global Initiative Dr....

TOPICS:
Advertisement

Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots

May 31, 2011 11:36 am | by U.S. Food & Drug Administration | Comments

Brand names of drospirenone-containing products include Yaz (generics Gianvi and Loryna), Yasmin (generics Ocella, Syeda, and Zarah), Beyaz, and Safyral.

MIM's Medical Imaging App for Patients, VueMe, Now Available on iPad, iPhone, and iPod touch

May 31, 2011 11:32 am | by Bio-Medicine.Org | Comments

CLEVELAND, May 31, 2011 /- MIM Software Inc., a leading global provider of medical imaging software, is proud to announce that the VueMe App for iPad, iPhone, and iPod touch is now available on the App Store. This new app, designed specifically for patient use, allows patients to view...

TOPICS:

First full-color display based on quantum dots

May 31, 2011 10:35 am | by I-Micronews | Comments

Moving from bulky cathode-ray televisions to slimline liquid-crystal and plasma displays not only frees up space in our homes and offices, but also has the added advantage of reducing energy consumption.

IMD Companies, Inc. Announces OMI Operations in Florida

May 31, 2011 9:34 am | by Bio-Medicine.Org | Comments

TAMPA, Fla., May 31, 2011 /- Following through with plans to expand its Medical Diagnostics operations, Optimum Mobile Imaging (OMI) has started services in Florida. Currently operating on a fee for service basis, OMI is submitting the paperwork necessary for insurance company contracting...

TOPICS:

Healthways elects director Ballantine as chairman

May 31, 2011 8:45 am | by The Associated Press | Comments

Healthways Inc., which operates wellness programs, announced Tuesday that John Ballantine, a director of the company since 2003, has been elected chairman of the board.He replaces Thomas Cigarran, a founder of the company and chairman since 1988, who chose not to seek re-election but will...

Advertisement

Elpida, PTI, and UMC partner on 3D IC integration development for advanced technologies including 28nm

May 31, 2011 8:36 am | by I-Micronews | Comments

Cooperation focuses on Through-Silicon Via (TSV) to establish a total 3D IC Logic+DRAM integration solution.

Final Published Trial Data in The Lancet Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil® Embolic System for Treatment of Cerebral Aneurysms

May 31, 2011 8:35 am | by Bio-Medicine.Org | Comments

TUSTIN, Calif., May 31, 2011 /- MicroVention-Terumo, Inc., a leader in developing, manufacturing and marketing interventional neurovascular devices, announced today the final 18-month follow-up data in a landmark international study. The HydroCoil® Endovascular Aneurysm Occlusion and...

TOPICS:

HeartSine® Increases AED System Warranty to Longest in the Industry

May 31, 2011 8:34 am | by Bio-Medicine.Org | Comments

NEWTOWN, Pa., May 31, 2011 /- HeartSine Technologies, Inc, a world leader in personal and public access defibrillators, has increased its system warranty period to an exclusive 10 years on its popular HeartSine ® samaritan ® PAD 300P Public Access Defibrillator (PAD) for the...

TOPICS:

Acurest's Custom CPAP Mask Now Available for Sleep Apnea Sufferers in the U.S.

May 31, 2011 8:34 am | by Bio-Medicine.Org | Comments

DALLAS, May 31, 2011 /- Acurest, the world's only provider of custom-made Continuous Positive Airway Pressure (CPAP) nasal masks for the treatment of sleep apnea disorder, announced that the solution is now available to sleep apnea sufferers in the U.S. Made specifically for each...

TOPICS:

Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer

May 31, 2011 8:33 am | by Bio-Medicine.Org | Comments

MALVERN, Pa., May 31, 2011 /- Fujirebio Diagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to the CYFRA 21-1™ EIA assay to monitor disease progression during the course of disease and treatment of lung cancer patients....

TOPICS:

Aveo deal with Centocor could be sweetened by up to $540M

May 31, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Cancer therapeutics company Aveo Pharmaceuticals Inc. said it will receive an initial $15 million and up to $540 million in milestone payments in an exclusive license agreement with Centocor Ortho Biotech Inc., related to Aveo's antibodies targeting the Recepteur d'Origine Nantais receptor.

Dyax expands Sigma-Tau partnership, potential payments

May 31, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Dyax Corp. has expanded a partnership with the Sigma-Tau SpA subsidiary Defiante Farmaceutica S.A. of Portugal, bringing the Cambridge biotech's under-the-skin treatment for hereditary angioedema, called DX-88 and marketed as Kalbitor, to more countries.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading